Sandoz launches the 1st version of multiple sclerosis drugs in US
Novartis International AG/ Sandoz reports US launch of Glatopa(TM), the first generic contender to Copaxone(R) 20mg. Processed and transmitted by NASDAQ OMX Corporate Solutions. Th
Login
X
- New Ventures
- Market Analysis
- Emerging Markets
- Technology
- Professional Services
- Media & Entertainment
- Manufacturing & Retail
- Logistics & Supply Chain
- Healthcare & Pharmaceutical
- Financial Services
- Energy
- Autos
- Aerospace & Defense
- Work-Life Balance
- Strategic Thinking
- Productivity
- Decision Making
- Communication
- Sustainability
- Success Story
- Power Players
- Philanthropy
- People
- Innovation
- CEO Magazine
